Applied therapeutics reports first quarter 2025 financial results

- company to present full 12-month clinical data and new topline 18-month and 24-month data from inspire registrational phase 3 trial of govorestat in cmt-sord deficiency at the peripheral nerve society 2025 annual meeting

APLT Ratings Summary

APLT Quant Ranking